Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ram Ron
24 years of experience
Clinic is certified :
Why choose Israel for lymphoma chemotherapy?
Access advanced Lymphoma chemotherapy solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Lymphoma chemotherapy | from $24,000 | from $3,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma chemotherapy journey.
Day 1
Day 2
Day 3-4
Day 5
Week 2-6
Week 7 onwards
Please note that the above timeline is a general guideline and individual cases may vary.
What patients like:
What patients don’t like:
As the leading global medical tourism platform, Bookimed.com provides information on Lymphoma chemotherapy facilities in Israel that is grounded in research, foresight, and expertise. All the content meets high interest related to the product and follows:
Bookimed forms its listings of Lymphoma chemotherapy clinics and doctors in Israel with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services in Israel.
Bookimed"s experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
Bookimed collects the opinions of Lymphoma chemotherapy patients in Israel only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. Bookimed strives to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best Lymphoma chemotherapy medical solutions from top medical services providers in Israel just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Bookimed"s blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Dr. Ram Ron specializes in lymphoma chemotherapy at Sourasky Medical Center (Ichilov), bringing extensive expertise to complex cases.
Dr. Ron Ram has performed several hundred stem cell transplants, demonstrating his deep expertise in lymphoma treatment at Sourasky Medical Center.
Head of Pediatric Oncohematology at Dana Dwek Children's Hospital – Dr. El Hasid specializes in bone marrow and umbilical blood transplantations. Has performed over 300 procedures.
Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.
Patients choose Israel for lymphoma treatment to access advanced cellular therapies and personalized medicine from world-leading hemato-oncologists. Centers like Sheba and Sourasky (Ichilov) offer in-house CAR T-cell manufacturing and next-generation immunotherapies, often providing faster access to life-saving protocols than hospitals in the United States or Canada.
Bookimed Expert Insight: While standard chemotherapy protocols are globally available, Israel's true advantage is accessibility to bi-specific antibodies and cellular therapies. For instance, Sheba Medical Center serves over 2,000,000 patients annually and provides CAR-T therapy to international patients outside of traditional clinical trials. This significantly broadens treatment windows for those with relapsed or refractory lymphoma.
Patient Consensus: Patients emphasize that traveling to Israel is most valuable for accessing experimental chemo-biologic therapies or specialized cell treatments unavailable elsewhere. They often highlight the significantly lower costs for complex procedures like CAR-T compared to commercial pricing in the US.
Israeli hematologists use advanced chemotherapy regimens like R-CHOP, ABVD, and DA-EPOCH-R, often combined with targeted biologics or immunotherapy. These protocols follow international NCCN and ESMO guidelines, achieving complete response rates up to 95% for specific lymphoma subtypes in recent clinical studies.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center offer a distinct advantage with in-house CAR-T cell manufacturing. While most global clinics wait weeks for external labs, these facilities process cellular therapies on-site. This significantly reduces the critical waiting period for patients with refractory lymphoma who have already exhausted standard chemotherapy lines.
Patient Consensus: Patients undergoing intensive 24-hour infusion regimens, such as DA-EPOCH-R, strongly recommend requesting a port catheter early. This proactive step improves comfort and protects veins during the multi-day treatment cycles common in Israeli hospitals.
Israeli oncology centers integrate chemotherapy with advanced immunotherapies and cellular treatments for lymphoma. Key innovations include CAR T-cell therapy, bispecific antibodies like Mosunetuzumab, and checkpoint inhibitors such as Nivolumab or Pembrolizumab. These smart therapies target cancer cells directly while significantly reducing long-term systemic toxicity.
Bookimed Expert Insight: Israeli hospitals like Sheba Medical Center operate their own GMP-certified manufacturing labs for CAR-T. This allows surgeons like Dr. Elad Jacoby to provide point-of-care cell therapies. These internal labs often make cutting-edge cellular treatments more accessible than at facilities relying on external global providers.
Patient Consensus: Patients advocate for Nivolumab + AVD as a newer standard for Hodgkin lymphoma to reduce side effects. Many emphasize exploring bispecific antibodies or clinical trials early if initial chemotherapy regimens show resistance.
Israeli doctors do not use excessive chemotherapy but prioritize personalized medicine and precision diagnostics to reduce toxic exposure. Most centers follow international protocols like RATHL, utilizing molecular testing and genetic mapping through Foundation One CDx to determine if biological therapies can replace or supplement traditional drugs.
Bookimed Expert Insight: While Israel is known for high-tech CAR-T therapy, the real advantage is early adoption of PET-CT-driven protocols. Leading oncologists like Dr. Abraham Avigdor at Sheba Medical Center often use interim scans to de-escalate treatment. This means if the tumor responds quickly, doctors may stop chemotherapy early to prevent long-term toxicity.
Patient Consensus: Patients note that treatments follow strict international guidelines, providing confidence that intensive cycles focus on preventing relapse. Many emphasize the availability of clinical trials that offer less toxic, novel immunotherapy options.
Lymphoma chemotherapy in Israel typically lasts 4 to 6 months, usually consisting of 6 treatment cycles. While standard protocols like R-CHOP or ABVD timeframe this duration, intensive cases involving stem cell transplants or advanced immunotherapies may extend the total medical timeline to 9 months.
Bookimed Expert Insight: Many patients overlook that Israel is a global leader in CAR T-cell therapy. Centers like Sheba Medical Center house in-house GMP-certified biotherapy labs. This allows doctors to transition patients to cellular immunotherapy faster than facilities that outsource cell processing. This integration can significantly streamline the treatment timeline for relapsed cases.
Patient Consensus: Patients report that while active infusions finish in six months, the emotional and physical fatigue lasts nearly a year. They often emphasize that session lengths are unpredictable, requiring full days at the oncology center.